We are live on
!
Find out more
EVM
Eaton Vance Management Portfolio holdings
AUM
$67.5B
1-Year Est. Return
11.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.7%
1 Year Est. Return
-11.44%
3 Year Est. Return
+49.6%
5 Year Est. Return
+94.25%
10 Year Est. Return
–
AUM
$46.6B
AUM Growth
+$944M
(+2.1%)
Cap. Flow
+$535M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
1,334
New
46
Increased
591
Reduced
399
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$97.9M |
| 2 |
Lowe's Companies
LOW
|
+$97.4M |
| 3 |
Elevance Health
ELV
|
+$81.4M |
| 4 |
Steel Dynamics
STLD
|
+$59.6M |
| 5 |
Marriott International
MAR
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$174M |
| 2 |
Ball Corp
BALL
|
+$103M |
| 3 |
Fortive
FTV
|
+$92.1M |
| 4 |
Home Depot
HD
|
+$63.8M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$50.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.9% |
| 2 | Financials | 16.29% |
| 3 | Healthcare | 14.22% |
| 4 | Consumer Discretionary | 11.55% |
| 5 | Communication Services | 10.43% |
Similar funds
ACM
JG
AII
MFRM
MA
5L
RC
W
Eaton Vance Management's Q3 2019 Portfolio in Review
As of Q3 2019, Eaton Vance Management held 1,334 positions worth $46.6B, up 2.1% from $45.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Eaton Vance Management's Q3 2019 filing shows 46 new, 591 increased, 399 reduced and 46 closed positions. Its largest new stake was Globe Life: 494,248 shares worth $47.3M. The largest sale was Johnson & Johnson, an estimated $174M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Eaton Vance Management's largest Q3 2019 buy was Globe Life: 494,248 shares worth $47.3M.
- Eaton Vance Management added most to Berkshire Hathaway Class B in Q3 2019, an estimated $97.9M increase.
- Eaton Vance Management's biggest Q3 2019 reduction was Johnson & Johnson, cutting an estimated $174M.
- Eaton Vance Management fully exited Sarepta Therapeutics in Q3 2019, selling an estimated $20.4M.
- Eaton Vance Management's ten largest holdings make up 21% of its $46.6B portfolio in Q3 2019.
- Eaton Vance Management opened 46 new positions and closed 46 in Q3 2019.
- Eaton Vance Management's portfolio value rose 2.1% quarter-over-quarter to $46.6B.
Based on Eaton Vance Management's 13F filing for Q3 2019, filed 14 Nov 2019.